Skip to content

PROTALIX BIOTHERAPEUTICS, INC.

PLX

CIK 0001006281

← back to feed
Revenue (TTM)
$77.37M
−1.2% YoY Q1 May 2026
Net Income (TTM)
$17.22M
−325.2% YoY Q1 May 2026
EPS Diluted (TTM)
$0.20
−300.0% YoY Q1 May 2026
Gross Margin
2.1%
Q1 May 2026
Operating Margin
26.2%
Q1 May 2026
Net Margin
22.3%
Q1 May 2026
Free Cash Flow (TTM)
$16.24M
Q1 May 2026
Cash
$41M
Q1 May 2026
Total Debt
$912K
Q1 May 2026
Shares Outstanding
80.57M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings